Malcolm Silander is invited to Chair a panel session at LSX World Congress 2024
Malcolm Silander, Co-founder of Precision BioSearch, was delighted to be invited to Chair a panel session at LSX – Partnering for Life Science Executives World Congress, held on 29th-30th May 2024 in London, UK.
Precision BioSearch Announced as Sponsor of Bio€quity Europe 2024
Precision BioSearch, a leading executive search partner specializing in the early-stage biotech sector, has announced its corporate sponsorship of Bio€quity Europe for a second consecutive year.
Precision BioSearch, sponsors of BIA UK Biotech Financing event
Precision BioSearch, a leading executive search partner to the early-stage biotech sector, is proud to announce its sponsorship of the BIA event, “UK Biotech Financing in 2024: A Year of Change and Opportunity”, held on 25th January 2024 at BMA House, London.
Our Co-founder, Malcolm Silander, presents at the OBN Awards 2023
Precision BioSearch was delighted to present Jonny Ohlson, Executive Chair and Founder, and Elena Stoyanova, Senior Scientist – New Technologies, of Touchlight with the award for ‘Best Established Biotech Company’ award at the OBN Awards 2023.
Precision BioSearch supports Pioneer Group’s ‘Launch Accelerator’ programme
Precision BioSearch Co-founder, Malcolm Silander, will deliver a half-day seminar to 14 Founders of the UK’s most exciting early-stage biotech companies as part of the Pioneer Group Launch Accelerator programme.
Jon Moore – Founding CEO
Pheno Therapeutics engaged Precision Biosearch to identify a new full-time CEO. We were very happy with the service we received. The Precision Biosearch team were able to provide a shortlist of candidates promptly and their notes on the candidates proved their ability to assess personality and fit to a start up culture in addition to […]
Myricx Bio partners with Precision BioSearch to appoint CSO
Precision BioSearch was delighted to partner with Myricx Bio, a biotech company focusing on the discovery and development of a completely novel class of selectively cytotoxic payloads for antibody-drug conjugates (ADCs), to secure the appointment of Dr Francesca Zammarchi as Chief Scientific Officer.
‘How to be an early-stage Biotech CEO in challenging times’, cited by Citeline – Duplicate – [#1444]
Our Co-founder, Malcolm Silander, chaired the discussion which formed the basis of Andrew McConaghie’s (In Vivo / Citeline) recent article, ‘How to be an early-stage Biotech CEO in challenging times’.
Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments – Duplicate – [#1430]
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease
Hiring with precision: candidate behaviours in a post-boom market – Duplicate – [#2634]
Biotech investment has taken a considerable downward turn over the past 18 months, impacted by the global macroeconomic situation and a return to lower levels of funding post-pandemic.